Envestnet Asset Management
IMUX icon

Envestnet Asset Management’s Immunic IMUX Stock Holding History

Envestnet Asset Management’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-5,511
Closed -$60.1K – 4499
2025
Q1 		$60.1K Buy
+5,511
New +$59.5K ﹤0.01% 4288

Other funds holding IMUX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Envestnet Asset Management's IMUX Position: Q2 2025 in Review

Envestnet Asset Management sold out of Immunic (IMUX) in Q2 2025, closing a stake of 5,511 shares — an estimated $60.1K sold.

Envestnet Asset Management first reported a position in IMUX in Q1 2025 and held it in 1 quarter. The position peaked at $60.1K in Q1 2025. 55 funds tracked by Wall St. Rank hold IMUX as of Q2 2025.

  • Envestnet Asset Management reported no remaining Immunic position as of Q2 2025 after selling out during the quarter.
  • Envestnet Asset Management sold 5,511 Immunic shares in Q2 2025, an estimated $60.1K.
  • Envestnet Asset Management first reported a position in Immunic in Q1 2025 and held it in 1 quarter.
  • Envestnet Asset Management's Immunic position peaked at $60.1K in Q1 2025.
  • 55 funds tracked by Wall St. Rank held Immunic as of Q2 2025.

Based on Envestnet Asset Management's 13F filing for Q2 2025, filed 1 Aug 2025.